Effect of endocrine therapy on quality of life and cognitive functions in patients with breast cancer.

Background: The use of endocrine therapy (ET) in postmenopausal breast cancer patients may affect their cognitive status. This study aims to assess the effects of tamoxifen and aromatase inhibitors (Als) on quality of life (QoL) and cognitive functions in breast cancer patients.

Patients And Methods: The study included 101 patients receiving tamoxifen, 97 patients receiving Als, and 95 patients without any ET.